Spray Venture Partners
Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies.
Business Model:
Revenue: $6.3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Spray Venture Partners Information
Geographic Data
Address: 2330 Washington St
City: Newton
State: MA
Zip: 02462
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Spray Venture Partners focuses exclusively on contributing capital and expertise to emerging healthcare technology companies. They work closely with clinical and technical founders to create companies that develop, market and deploy innovative technologies to meet major unmet healthcare needs.
Contact Phone:
+16173326060
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2005 | Direct Flow Medical | Series A | 8.4M |
| 1/2001 | Intrinsic Therapeutics | Series B | 7.2M |
| 8/2007 | Leptos Biomedical | Series C | 20M |
| 1/2011 | PneumRx | Venture Round | 0 |
| 10/2013 | Conventus Orthopaedics | Venture Round | 0 |
| 6/2009 | Facet Solutions | Debt Financing | 4.1M |
| 6/2002 | Confluent Surgical | Series C | 20M |
| 3/2007 | PneumRx | Series B | 0 |
| 1/2013 | Tryton Medical | Unattributed | 24M |
| 2/2010 | Intrinsic Therapeutics | Venture Round | 18M |
| 12/2005 | Facet Solutions | Series B | 16.5M |
| 10/2007 | Direct Flow Medical | Series B | 27M |
| 10/2003 | Cotherix | Series C | 55M |
| 5/2010 | TearScience | Series C | 44.5M |
| 12/2002 | Intrinsic Therapeutics | Series C | 25M |
| 7/2009 | Interlace Medical | Series C | 20.5M |
| 9/2007 | Intrinsic Therapeutics | Series D | 21M |
| 4/2012 | Direct Flow Medical | Venture Round | 0 |
| 8/2006 | Interlace Medical | Series A | 750k |
| 1/2007 | TearScience | Series B | 15.1M |
| 8/2006 | Solace Therapeutics | Series B | 3M |
| 7/2005 | TearScience | Series A | 100k |
| 4/2008 | Tryton Medical | Series C | 14M |
| 2/2004 | Facet Solutions | Series A | - |
| 10/2009 | Direct Flow Medical | Series C | 40M |
| 9/2010 | Tryton Medical | Series D | 20M |
| 5/2007 | Interlace Medical | Series B | 3M |
| 7/2008 | Interlace Medical | Series B | 7M |
| 3/2000 | Intrinsic Therapeutics | Series A | - |
| 3/2012 | Solace Therapeutics | Equity | 7M |
| 10/2013 | Conventus Orthopaedics | Venture Round | 0 |
| 1/2013 | Tryton Medical | Venture Round | 0 |
| 4/2012 | Direct Flow Medical | Venture Round | 0 |
| 3/2012 | Solace Therapeutics | Venture Round | 0 |
| 1/2011 | PneumRx | Venture Round | 0 |
| 9/2010 | Tryton Medical | Series D | 0 |
| 5/2010 | TearScience | Series C | 0 |
| 2/2010 | Intrinsic Therapeutics | Venture Round | 0 |
| 10/2009 | Direct Flow Medical | Series C | 0 |
| 7/2009 | Interlace Medical | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
